Neurocrine Biosciences

Neurocrine Biosciences is a neuroscience-focused, biopharmaceutical company dedicated to developing life-changing treatments for patients with under-addressed neurological, neuroendocrine, and neuropsychiatric disorders. Founded in 1992 by scientists with a passion for discovery, Neurocrine has established a strong track record in developing innovative therapies, including FDA-approved treatments for tardive dyskinesia, Huntington’s disease chorea, endometriosis, and uterine fibroids.

The company is committed to advancing science and bringing hope to underserved patients, as reflected in its robust pipeline of investigational therapies across its core therapeutic areas. Neurocrine maintains a strong culture built on collaboration, integrity, and tenacity, and strives to provide a positive and inclusive work environment for its employees.

Neurocrine Biosciences offers a hybrid and flexible work arrangement, allowing for a balance between in-office and remote work. The company provides resources for total well-being, including on-site fitness facilities and virtual mental health appointments, demonstrating its commitment to supporting employee health and work-life balance.

Neurocrine Biosciences offers a comprehensive benefits package designed to support employees' overall well-being. The package includes physical health benefits such as medical, dental, and vision plans, as well as on-site fitness facilities. Emotional health benefits include access to health coaching, a well-being portal, annual wellness incentives, and virtual mental health appointments. Financial health benefits include a retirement savings plan with company match, supplemental life insurance, tuition reimbursement, flexible spending accounts, and other options. Additional benefits include hybrid and flexible work arrangements, medical travel reimbursement, dependent care flex savings, employee resource networks, and various leave of absence programs.

Neurocrine Biosciences is a neuroscience-focused biopharmaceutical company dedicated to relieving suffering for people with significant needs but limited treatment options. Their mission centers on developing innovative therapies for neurological, neuroendocrine, and neuropsychiatric disorders, focusing on under-addressed and rare diseases where conventional approaches fall short. Their approach emphasizes scientific discovery, robust research and development, and a commitment to bringing life-changing treatments to market.

Neurocrine Biosciences promotes a culture of collaboration, tenacity, integrity, and innovation. They value their employees and are dedicated to fostering an inclusive work environment where diverse voices are encouraged and respected. They are passionate about their work and committed to making a difference in the lives of patients with rare and under-addressed diseases.

Neurocrine Biosciences actively promotes diversity, equity, and inclusion by fostering a collaborative culture that values unique perspectives and experiences. They are signatories to Biocom California's DE&I Member Pledge, have a dedicated full-time DE&I leader, and operate a DE&I council that advises on company initiatives. They support employee resource networks, unconscious bias training, and various celebrations of different cultural and heritage observances. Additionally, they partner with organizations dedicated to increasing STEM representation among underrepresented groups.